Hub : Traits :

Reaction Time

256 significantly associated models · 79 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 43757762 45187285 1 1 2.5e-08 5.2e-06 3.9e-02 80 SLC6A9
2 1 48301764 51180660 1 1 1.2e-07 2.7e-08 6.7e-02 89 AGBL4
3 1 96492298 97978299 1 1 1.0e-09 3.0e-08 3.0e-01 96 PTBP2
4 1 173437024 175663031 1 1 1.0e-07 1.1e-05 1.2e-01 88 RABGAP1L
5 1 204991770 206329620 4 1 7.2e-08 2.0e-07 1.0e+00 100 NUCKS1
6 2 23453834 25278723 4 1 9.4e-09 4.7e-08 5.8e-03 74 AC009228.1
7 2 43844833 45285952 1 1 2.4e-08 7.6e-07 7.2e-02 87 PREPL
8 2 55483020 57309754 2 1 6.5e-09 2.5e-09 1.4e-02 83 CCDC85A
9 2 70804467 72356449 1 1 1.3e-07 4.2e-08 1.0e+00 100 ZNF638
10 2 174136944 176043097 5 1 6.7e-10 5.7e-10 3.5e-02 88 OLA1
11 2 200086752 202078494 3 1 1.0e-10 4.0e-12 3.6e-03 82 SPATS2L
12 3 46365783 47846566 1 1 2.4e-07 2.3e-07 4.6e-02 85 SETD2
13 5 111499732 112950045 5 1 4.1e-11 3.0e-11 7.7e-02 93 REEP5
14 5 138933151 140423473 2 1 5.0e-08 2.5e-09 1.7e-03 72 PFDN1
15 6 108183628 109704062 1 1 9.9e-09 7.7e-12 1.8e-04 70 FOXO3
16 7 44090853 45498400 1 1 3.8e-07 5.1e-10 2.4e-05 54 ZMIZ2
17 7 122978928 124733550 1 1 1.8e-08 3.1e-08 1.4e-03 67 RP5-921G16.1
18 9 85899677 87315117 1 1 3.4e-08 4.7e-08 9.1e-02 90 RMI1
19 10 12239118 13839729 1 1 1.4e-09 1.3e-06 1.8e-02 76 CCDC3
20 11 45929961 47953477 9 1 4.5e-11 2.1e-09 7.5e-02 91 ARHGAP1
21 11 63295034 64687797 1 1 7.3e-08 1.7e-07 5.1e-01 98 TRPT1
22 12 10158903 11564511 1 1 3.9e-07 1.4e-07 1.4e-01 92 CSDA
23 12 48605088 50364707 7 1 5.4e-11 2.4e-12 4.6e-03 84 CCDC65
24 12 111154626 113517494 12 1 1.4e-11 1.4e-11 4.9e-02 92 ACAD10
25 16 55526487 57089130 1 1 7.6e-08 2.2e-08 1.2e-01 92 GNAO1
26 17 6456609 7856438 1 1 6.2e-08 2.2e-06 1.7e-02 74 C17orf81
27 17 43871147 45510971 8 1 5.1e-24 9.1e-20 8.0e-01 100 ARL17A
28 20 46840115 48410403 2 1 8.4e-08 1.4e-06 3.3e-01 96 ARFGEF2

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Verbal and Numeric Reasoning (VNR) 4.04 8 2 6.1 -0.02 9.6e-01 ARFGEF2 ARHGAP1 ARL17A CCDC65 FOXO3 PFDN1 RABGAP1L ZNF638
Breast Cancer 1.09 2 0 0.0 0.00 1.0e+00 C17orf81 SLC6A9
Prostate Cancer 1.54 1 0 0.0 0.00 1.0e+00 NUCKS1
Coronary Artery Disease (CAD) 1.83 1 0 0.0 0.00 1.0e+00 ACAD10
LDL Cholesterol 2.07 1 1 3.0 0.00 1.0e+00 ACAD10
Primary Biliary Cirrhosis 1.76 1 0 0.0 0.00 1.0e+00 ACAD10
Schizophrenia 2.04 2 0 0.0 0.00 1.0e+00 ARHGAP1 PTBP2
Blood Eosinophil Count 5.19 2 2 6.1 0.00 1.0e+00 ACAD10 RMI1
Blood Platelet Count 1.28 5 4 12.1 -0.62 2.7e-01 ACAD10 ARL17A C17orf81 RMI1 TRPT1
Blood Red Count 1.57 5 2 6.1 0.04 9.4e-01 AC009228.1 ACAD10 ARFGEF2 SLC6A9 SPATS2L
Blood White Count 4.17 6 4 12.1 0.14 7.9e-01 AC009228.1 ACAD10 AGBL4 RMI1 SETD2 ZNF638
Heel T-Score 2.10 9 5 15.2 0.12 7.7e-01 ARHGAP1 ARL17A C17orf81 CCDC65 CSDA RABGAP1L REEP5 SETD2 ZNF638
BMI 2.43 9 5 15.2 -0.47 2.0e-01 AGBL4 ARFGEF2 FOXO3 NUCKS1 OLA1 PFDN1 PTBP2 REEP5 TRPT1
Height 2.31 14 10 30.3 0.07 8.1e-01 AC009228.1 ACAD10 ARFGEF2 ARL17A CCDC3 CCDC85A FOXO3 NUCKS1 RABGAP1L REEP5 RMI1 RP5-921G16.1 ZMIZ2 ZNF638
Waist Hip Ratio (WHR) 1.14 2 1 3.0 0.00 1.0e+00 ARL17A SETD2
Systolic Blood Pressure 3.10 8 4 12.1 0.37 3.7e-01 ACAD10 ARFGEF2 ARL17A C17orf81 FOXO3 OLA1 SPATS2L ZNF638
Smoking Status 2.60 4 1 3.0 -0.58 4.2e-01 AGBL4 OLA1 RABGAP1L SLC6A9
Allergy or Eczema 1.23 1 0 0.0 0.00 1.0e+00 ACAD10
Cardiovascular Disease 2.24 3 2 6.1 0.00 1.0e+00 ACAD10 ARL17A OLA1
Hypothyroidism (self reported) 3.85 1 1 3.0 0.00 1.0e+00 ACAD10
Lung FEV1/FVC ratio 1.55 3 2 6.1 0.00 1.0e+00 ARFGEF2 FOXO3 NUCKS1
Lung FVC 1.69 6 3 9.1 -0.52 2.9e-01 ARFGEF2 ARL17A C17orf81 FOXO3 RMI1 SPATS2L
Neuroticism 2.30 5 0 0.0 -0.20 7.5e-01 AC009228.1 ARHGAP1 ARL17A CCDC85A RABGAP1L
Chronotype (morning person) 2.16 3 1 3.0 0.00 1.0e+00 ACAD10 AGBL4 RMI1
Hair Pigment 0.19 4 3 9.1 -0.12 8.8e-01 ACAD10 CCDC65 FOXO3 NUCKS1
Tanning 0.24 1 0 0.0 0.00 1.0e+00 ACAD10
Hand grip strength (left) 1.90 2 1 3.0 0.00 1.0e+00 NUCKS1 ZNF638
Number of treatments/medications taken 2.04 2 0 0.0 0.00 1.0e+00 ACAD10 RABGAP1L
Sensitivity / hurt feelings 1.48 1 0 0.0 0.00 1.0e+00 ARL17A
Frequency of depressed mood in last 2 weeks 2.87 3 1 3.0 0.00 1.0e+00 ARFGEF2 ARHGAP1 CCDC85A
Relative age of first facial hair 1.65 1 0 0.0 0.00 1.0e+00 FOXO3
Ever had hysterectomy (womb removed) 1.36 1 0 0.0 0.00 1.0e+00 RABGAP1L
Systolic blood pressure, automated reading 2.22 4 2 6.1 -0.29 7.1e-01 ACAD10 ARL17A C17orf81 OLA1
Vitamin and mineral supplements 1.48 1 0 0.0 0.00 1.0e+00 SETD2
Pack years adult smoking proportion 1.69 1 0 0.0 0.00 1.0e+00 AGBL4
Impedance of leg (right) 1.61 7 1 3.0 -0.09 8.5e-01 AC009228.1 CCDC65 FOXO3 GNAO1 NUCKS1 PFDN1 SPATS2L
Leg fat-free mass (left) 2.53 10 6 18.2 0.54 1.1e-01 ACAD10 AGBL4 FOXO3 GNAO1 NUCKS1 OLA1 PTBP2 REEP5 ZMIZ2 ZNF638
Trunk fat percentage 2.01 7 2 6.1 0.53 2.2e-01 AGBL4 ARL17A FOXO3 OLA1 PTBP2 RMI1 TRPT1
Hand grip strength (right) 1.71 3 1 3.0 0.00 1.0e+00 ARFGEF2 NUCKS1 ZNF638
Townsend deprivation index at recruitment 1.15 1 0 0.0 0.00 1.0e+00 AGBL4
Current tobacco smoking 1.97 2 0 0.0 0.00 1.0e+00 AGBL4 CCDC65
Fed-up feelings 2.78 3 0 0.0 0.00 1.0e+00 AC009228.1 ACAD10 ARHGAP1
Relative age voice broke 1.44 1 0 0.0 0.00 1.0e+00 FOXO3
Taking other prescription medications 2.01 2 0 0.0 0.00 1.0e+00 ACAD10 RABGAP1L
Age when periods started (menarche) 1.99 2 2 6.1 0.00 1.0e+00 CCDC65 FOXO3
Heel bone mineral density (BMD) T-score, automated (left) 1.42 1 1 3.0 0.00 1.0e+00 ARHGAP1
High blood pressure 2.25 3 1 3.0 0.00 1.0e+00 ACAD10 ARL17A OLA1
Multivitamins +/- minerals 1.46 1 0 0.0 0.00 1.0e+00 NUCKS1
Medication: Atenolol 1.78 1 0 0.0 0.00 1.0e+00 ACAD10
Medication: Levothyroxine sodium 3.63 1 1 3.0 0.00 1.0e+00 ACAD10
Sitting height 2.60 8 6 18.2 -0.14 7.4e-01 AC009228.1 ARFGEF2 ARL17A CCDC3 FOXO3 NUCKS1 REEP5 ZNF638
Body mass index (BMI) 2.09 5 4 12.1 0.57 3.2e-01 AGBL4 FOXO3 OLA1 PTBP2 TRPT1
Impedance of leg (left) 1.68 5 1 3.0 0.19 7.5e-01 AC009228.1 GNAO1 NUCKS1 PFDN1 SPATS2L
Leg predicted mass (left) 2.52 10 7 21.2 0.54 1.1e-01 ACAD10 AGBL4 FOXO3 GNAO1 NUCKS1 OLA1 PTBP2 REEP5 ZMIZ2 ZNF638
Trunk fat mass 2.33 9 3 9.1 0.43 2.4e-01 AGBL4 ARL17A FOXO3 OLA1 PTBP2 REEP5 RMI1 TRPT1 ZMIZ2
Waist circumference 2.10 5 2 6.1 0.40 5.1e-01 ACAD10 AGBL4 FOXO3 OLA1 REEP5
Past tobacco smoking 2.58 4 0 0.0 0.63 3.7e-01 ACAD10 OLA1 PREPL RABGAP1L
Alcohol usually taken with meals 1.89 1 0 0.0 0.00 1.0e+00 RABGAP1L
Nervous feelings 2.03 3 0 0.0 0.00 1.0e+00 AGBL4 ARL17A CCDC85A
Frequency of tenseness / restlessness in last 2 weeks 2.58 2 0 0.0 0.00 1.0e+00 ARL17A RABGAP1L
Hearing difficulty/problems with background noise 2.29 2 0 0.0 0.00 1.0e+00 ARHGAP1 NUCKS1
Forced vital capacity (FVC) 1.76 4 2 6.1 0.29 7.1e-01 ARFGEF2 ARL17A SPATS2L ZNF638
Heel bone mineral density (BMD) T-score, automated (right) 1.34 1 1 3.0 0.00 1.0e+00 ARHGAP1
Qualifications: None of the above 2.68 4 1 3.0 -0.57 4.3e-01 ARFGEF2 FOXO3 SLC6A9 SPATS2L
Fluid intelligence score 3.24 6 2 6.1 0.14 7.9e-01 ARFGEF2 ARHGAP1 CCDC65 FOXO3 PFDN1 ZNF638
Illnesses of siblings 1.80 1 0 0.0 0.00 1.0e+00 ACAD10
Neuroticism score 1.96 4 0 0.0 0.24 7.6e-01 ARHGAP1 ARL17A CCDC85A RABGAP1L
Weight 2.61 11 5 15.2 0.53 9.0e-02 ACAD10 AGBL4 ARL17A FOXO3 NUCKS1 OLA1 PTBP2 REEP5 TRPT1 ZMIZ2 ZNF638
Impedance of arm (right) 2.26 6 3 9.1 -0.02 9.7e-01 ACAD10 ARL17A FOXO3 NUCKS1 REEP5 RMI1
Arm fat percentage (right) 2.01 7 2 6.1 0.70 8.1e-02 AGBL4 ARFGEF2 ARL17A FOXO3 OLA1 PTBP2 TRPT1
Trunk fat-free mass 2.65 9 5 15.2 0.16 6.9e-01 AC009228.1 ACAD10 AGBL4 ARFGEF2 FOXO3 NUCKS1 REEP5 ZMIZ2 ZNF638
Hip circumference 2.07 7 4 12.1 0.77 4.2e-02 ACAD10 AGBL4 FOXO3 OLA1 PTBP2 TRPT1 ZMIZ2
Time employed in main current job 1.85 1 0 0.0 0.00 1.0e+00 OLA1
Frequency of tiredness / lethargy in last 2 weeks 2.50 3 0 0.0 0.00 1.0e+00 ACAD10 ARFGEF2 ARHGAP1
Number of live births 0.98 1 0 0.0 0.00 1.0e+00 TRPT1
Forced expiratory volume in 1-second (FEV1) 1.61 2 2 6.1 0.00 1.0e+00 ARFGEF2 ARL17A
Happiness 1.32 1 0 0.0 0.00 1.0e+00 ARFGEF2
Qualifications: A levels/AS levels or equivalent 2.31 3 0 0.0 0.00 1.0e+00 ARFGEF2 SLC6A9 SPATS2L
Prospective memory result 2.05 1 0 0.0 0.00 1.0e+00 ZNF638
Forced expiratory volume in 1-second (FEV1), Best measure 1.35 2 2 6.1 0.00 1.0e+00 ARFGEF2 ARL17A
Impedance of arm (left) 2.30 8 3 9.1 -0.15 7.3e-01 ACAD10 AGBL4 ARL17A FOXO3 OLA1 REEP5 RMI1 SPATS2L
Arm fat mass (right) 2.35 8 3 9.1 0.53 1.7e-01 AGBL4 ARL17A FOXO3 OLA1 PTBP2 REEP5 TRPT1 ZMIZ2
Trunk predicted mass 2.67 9 5 15.2 0.16 6.7e-01 AC009228.1 ACAD10 AGBL4 ARFGEF2 FOXO3 NUCKS1 REEP5 ZMIZ2 ZNF638
Standing height 2.26 11 7 21.2 -0.05 8.9e-01 AC009228.1 ACAD10 ARFGEF2 ARL17A CCDC3 FOXO3 NUCKS1 REEP5 RMI1 ZMIZ2 ZNF638
Tense / 'highly strung' 1.91 2 1 3.0 0.00 1.0e+00 NUCKS1 RABGAP1L
Hair/balding pattern: Pattern 4 1.24 1 0 0.0 0.00 1.0e+00 ARL17A
Birth weight of first child 2.43 2 1 3.0 0.00 1.0e+00 ACAD10 ARFGEF2
Peak expiratory flow (PEF) 2.29 3 1 3.0 0.00 1.0e+00 ARL17A FOXO3 NUCKS1
Pulse wave reflection index 1.90 1 0 0.0 0.00 1.0e+00 RMI1
Qualifications: O levels/GCSEs or equivalent 2.86 3 0 0.0 0.00 1.0e+00 ARFGEF2 RMI1 SLC6A9
Medication: Paracetamol 1.32 1 0 0.0 0.00 1.0e+00 RABGAP1L
Headache pain in last month 1.78 2 0 0.0 0.00 1.0e+00 ACAD10 RABGAP1L
Gout (self-reported) 1.16 1 0 0.0 0.00 1.0e+00 ACAD10
Hypothyroidism/myxoedema (self-reported) 3.38 1 1 3.0 0.00 1.0e+00 ACAD10
Birth weight 3.37 2 2 6.1 0.00 1.0e+00 ACAD10 C17orf81
High blood pressure (siblings) 1.54 1 0 0.0 0.00 1.0e+00 ACAD10
Forced vital capacity (FVC), Best measure 1.73 3 3 9.1 0.00 1.0e+00 ARFGEF2 ARL17A ZNF638
Body fat percentage 2.02 7 1 3.0 0.72 6.8e-02 AGBL4 ARFGEF2 ARL17A FOXO3 OLA1 PTBP2 TRPT1
Leg fat percentage (right) 2.03 6 1 3.0 0.66 1.5e-01 AGBL4 ARFGEF2 FOXO3 OLA1 PTBP2 TRPT1
Arm fat-free mass (right) 2.61 8 6 18.2 0.60 1.1e-01 ACAD10 AGBL4 FOXO3 NUCKS1 PTBP2 REEP5 ZMIZ2 ZNF638
Comparative body size at age 10 1.93 3 2 6.1 0.00 1.0e+00 ARL17A CCDC65 NUCKS1
Seen a psychiatrist for nerves, anxiety, tension or depression 1.64 1 0 0.0 0.00 1.0e+00 NUCKS1
Qualifications: College or University degree 2.26 5 2 6.1 0.32 6.0e-01 ARFGEF2 FOXO3 RABGAP1L SLC6A9 SPATS2L
Medication for pain relief, constipation, heartburn 1.86 1 1 3.0 0.00 1.0e+00 RABGAP1L
Medication: Blood pressure 1.69 1 0 0.0 0.00 1.0e+00 ACAD10
Medication: Allopurinol 1.28 1 0 0.0 0.00 1.0e+00 ACAD10
Medication: Seretide 50 evohaler 1.45 1 0 0.0 0.00 1.0e+00 AC009228.1
Mean time to correctly identify matches 17.08 28 20 60.6 -0.99 8.1e-27 AC009228.1 ACAD10 AGBL4 ARFGEF2 ARHGAP1 ARL17A C17orf81 CCDC3 CCDC65 CCDC85A CSDA FOXO3 GNAO1 NUCKS1 OLA1 PFDN1 PREPL PTBP2 RABGAP1L REEP5 RMI1 RP5-921G16.1 SETD2 SLC6A9 SPATS2L TRPT1 ZMIZ2 ZNF638
Heart disease (mother) 1.28 1 0 0.0 0.00 1.0e+00 ACAD10
Whole body fat mass 2.35 9 2 6.1 0.59 9.8e-02 ACAD10 AGBL4 ARL17A FOXO3 OLA1 PTBP2 REEP5 TRPT1 ZMIZ2
Leg fat mass (right) 2.37 7 4 12.1 0.52 2.3e-01 ACAD10 AGBL4 FOXO3 OLA1 PTBP2 REEP5 TRPT1
Arm predicted mass (right) 2.63 9 6 18.2 0.40 2.8e-01 ACAD10 AGBL4 ARFGEF2 FOXO3 NUCKS1 PTBP2 REEP5 ZMIZ2 ZNF638
Pulse rate, automated reading 2.00 4 1 3.0 -0.20 8.0e-01 CCDC65 RABGAP1L SPATS2L TRPT1
Alcohol intake frequency. 0.95 1 0 0.0 0.00 1.0e+00 AC009228.1
Comparative height size at age 10 2.57 9 6 18.2 -0.05 9.0e-01 ACAD10 ARFGEF2 ARL17A CCDC3 FOXO3 NUCKS1 REEP5 RMI1 ZNF638
Suffer from 'nerves' 2.70 1 0 0.0 0.00 1.0e+00 ARHGAP1
Overall health rating 1.21 1 0 0.0 0.00 1.0e+00 SPATS2L
Chest pain or discomfort 1.82 2 0 0.0 0.00 1.0e+00 C17orf81 REEP5
Family relationship satisfaction 1.04 1 0 0.0 0.00 1.0e+00 ARFGEF2
Qualifications: NVQ or HND or HNC or equivalent 1.31 1 0 0.0 0.00 1.0e+00 ACAD10
Supplements: Vitamin C 1.48 1 0 0.0 0.00 1.0e+00 RMI1
Knee pain experienced in last month 1.38 1 0 0.0 0.00 1.0e+00 RABGAP1L
Hypertension (Self-reported) 2.08 4 1 3.0 -0.09 9.1e-01 ACAD10 ARL17A CSDA OLA1
Smoking status: Previous 2.79 3 0 0.0 0.00 1.0e+00 ACAD10 PREPL RABGAP1L
Forced expiratory volume in 1-second (FEV1), predicted 1.36 1 0 0.0 0.00 1.0e+00 ZNF638
Whole body fat-free mass 2.68 10 6 18.2 0.25 4.8e-01 AC009228.1 ACAD10 AGBL4 ARFGEF2 FOXO3 NUCKS1 PTBP2 REEP5 ZMIZ2 ZNF638
Leg fat-free mass (right) 2.47 10 4 12.1 0.40 2.5e-01 AC009228.1 ACAD10 AGBL4 FOXO3 GNAO1 NUCKS1 PTBP2 REEP5 ZMIZ2 ZNF638
Arm fat percentage (left) 1.82 7 1 3.0 0.71 7.6e-02 AGBL4 ARFGEF2 ARL17A FOXO3 OLA1 PTBP2 TRPT1
Handedness (chirality/laterality): Left-handed 1.85 1 1 3.0 0.00 1.0e+00 ARL17A
Mood swings 2.07 1 0 0.0 0.00 1.0e+00 ACAD10
Loneliness, isolation 2.59 3 1 3.0 0.00 1.0e+00 ACAD10 ARFGEF2 ARHGAP1
Long-standing illness, disability or infirmity 1.58 1 0 0.0 0.00 1.0e+00 CSDA
Qualifications: nursing, teaching 1.51 1 0 0.0 0.00 1.0e+00 RMI1
Medication for cholesterol 1.54 1 0 0.0 0.00 1.0e+00 ACAD10
Back pain experienced in last month 1.79 1 0 0.0 0.00 1.0e+00 ACAD10
Illnesses of father: None of the above (group 1) 1.96 1 0 0.0 0.00 1.0e+00 ACAD10
Smoking status: Current 2.04 2 0 0.0 0.00 1.0e+00 AGBL4 CCDC65
Whole body water mass 2.65 10 6 18.2 0.25 4.8e-01 AC009228.1 ACAD10 AGBL4 ARFGEF2 FOXO3 NUCKS1 PTBP2 REEP5 ZMIZ2 ZNF638
Leg predicted mass (right) 2.46 10 4 12.1 0.39 2.6e-01 AC009228.1 ACAD10 AGBL4 FOXO3 GNAO1 NUCKS1 PTBP2 REEP5 ZMIZ2 ZNF638
Arm fat mass (left) 2.28 8 3 9.1 0.53 1.8e-01 AGBL4 ARL17A FOXO3 OLA1 PTBP2 REEP5 TRPT1 ZMIZ2
Number of self-reported non-cancer illnesses 2.17 2 0 0.0 0.00 1.0e+00 ACAD10 OLA1
Miserableness 2.37 2 0 0.0 0.00 1.0e+00 AC009228.1 RABGAP1L
Guilty feelings 1.56 1 0 0.0 0.00 1.0e+00 AC009228.1
Medication: Blood pressure 1.92 1 1 3.0 0.00 1.0e+00 ACAD10
Medication: Bendroflumethiazide 1.73 1 0 0.0 0.00 1.0e+00 ACAD10
Medication: Paracetamol 1.26 1 0 0.0 0.00 1.0e+00 RABGAP1L
Basal metabolic rate 2.73 9 6 18.2 0.54 1.3e-01 ACAD10 AGBL4 FOXO3 NUCKS1 OLA1 PTBP2 REEP5 ZMIZ2 ZNF638
Leg fat percentage (left) 1.85 6 1 3.0 0.69 1.3e-01 AGBL4 ARFGEF2 FOXO3 OLA1 PTBP2 TRPT1
Arm fat-free mass (left) 2.77 8 6 18.2 0.62 1.0e-01 ACAD10 AGBL4 FOXO3 NUCKS1 PTBP2 REEP5 ZMIZ2 ZNF638
Diastolic blood pressure, automated reading 2.41 3 1 3.0 0.00 1.0e+00 ACAD10 GNAO1 OLA1
Ever depressed for a whole week 1.26 1 0 0.0 0.00 1.0e+00 ARFGEF2
Vascular/heart problems diagnosed by doctor 2.20 3 1 3.0 0.00 1.0e+00 ACAD10 OLA1 SPATS2L
Pain experienced in last month 2.07 2 0 0.0 0.00 1.0e+00 ACAD10 RABGAP1L
Pack years of smoking 1.64 1 0 0.0 0.00 1.0e+00 AGBL4
Impedance of whole body 2.09 9 3 9.1 -0.26 5.0e-01 ACAD10 ARL17A FOXO3 GNAO1 NUCKS1 OLA1 PFDN1 RMI1 SPATS2L
Leg fat mass (left) 2.31 7 2 6.1 0.53 2.2e-01 ACAD10 AGBL4 FOXO3 OLA1 PTBP2 REEP5 TRPT1
Arm predicted mass (left) 2.72 8 6 18.2 0.62 1.0e-01 ACAD10 AGBL4 FOXO3 NUCKS1 PTBP2 REEP5 ZMIZ2 ZNF638

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 7 0.2004 1.94
GTEx Adipose Visceral Omentum 4 0.1962 1.97
GTEx Adrenal Gland 5 0.3429 2.07
GTEx Artery Aorta 9 0.3020 1.98
GTEx Artery Coronary 2 0.1688 2.00
GTEx Artery Tibial 9 0.2392 2.05
GTEx Brain Caudate basal ganglia 1 0.1085 1.93
GTEx Brain Cerebellar Hemisphere 2 0.1342 1.99
GTEx Brain Cerebellum 3 0.1512 2.00
GTEx Brain Cortex 3 0.2896 1.97
GTEx Brain Frontal Cortex BA9 3 0.3240 2.11
GTEx Brain Hippocampus 1 0.1901 1.97
GTEx Brain Hypothalamus 1 0.1692 1.95
GTEx Brain Nucleus accumbens basal ganglia 4 0.4619 2.13
GTEx Brain Putamen basal ganglia 1 0.1600 2.03
GTEx Breast Mammary Tissue 4 0.2024 2.03
GTEx Breast Mammary Tissue (Male) 2 0.1675 1.87
GTEx Breast Mammary Tissue (Female) 3 0.1823 1.96
GTEx Cells EBV-transformed lymphocytes 2 0.1405 1.90
GTEx Cells Transformed fibroblasts 8 0.1904 1.89
GTEx Colon Sigmoid 3 0.2051 2.05
GTEx Colon Transverse 7 0.3387 2.06
GTEx Esophagus Gastroesophageal Junction 6 0.4147 2.10
GTEx Esophagus Mucosa 7 0.2107 1.99
GTEx Esophagus Muscularis 9 0.2783 2.08
GTEx Heart Atrial Appendage 2 0.1265 2.02
GTEx Heart Left Ventricle 2 0.1305 2.10
GTEx Liver 5 0.6964 2.26
GTEx Lung 5 0.1739 1.97
GTEx Muscle Skeletal 8 0.2765 2.07
GTEx Nerve Tibial 9 0.2080 2.02
GTEx Ovary 3 0.3297 2.01
GTEx Pancreas 3 0.1837 1.95
GTEx Pituitary 7 0.6272 2.21
GTEx Prostate 2 0.2395 1.99
GTEx Skin Not Sun Exposed Suprapubic 9 0.3656 2.00
GTEx Skin Sun Exposed Lower leg 14 0.3846 2.03
GTEx Small Intestine Terminal Ileum 1 0.2165 1.90
GTEx Spleen 3 0.2125 1.96
GTEx Stomach 4 0.2747 1.93
GTEx Testis 12 0.3801 2.06
GTEx Thyroid 12 0.2999 2.02
GTEx Uterus 1 0.1761 1.81
GTEx Vagina 0 0.0000 1.95
GTEx Whole Blood 1 0.0502 1.98
METSIM Adipose 5 0.1085 1.87
NTR Blood 3 0.1248 1.69
ROSMAP Brain Pre-frontal Cortex 5 0.1139 1.93
YFS Blood 6 0.1299 1.75
CommonMind Brain Pre-frontal Cortex 11 0.2045 1.91
TCGA Breast Tumor 1 0.1304 1.81
TCGA Breast Normal 5 0.1188 1.67
TCGA Ovarian Tumor 7 0.2395 1.71
TCGA Prostate Tumor 4 0.1156 1.73